NCT07467772 2026-03-12
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Dana-Farber Cancer Institute
Phase 2 Not yet recruiting
Dana-Farber Cancer Institute
European Institute of Oncology
West German Study Group
Azienda Ospedaliero-Universitaria Careggi